CDH5 and acute chest syndrome: We similarly examined VE-cadherin and quantified its abundance at the plasma membrane in endothelial cells treated with no EVs, with EVs from control subjects, or with EVs from subjects with SCD at baseline or during an episode of ACS (Figure 4).